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Abstract
 
Lymph-borne, soluble factors (e.g., chemokines and others) influence lymphocyte recirculation
and endothelial phenotype at high endothelial venules (HEVs) in lymph node cortex. Yet the
route lymph-borne soluble molecules travel from the subcapsular sinus to the HEVs is unclear.
Therefore, we injected subcutaneously into mice and rats a wide variety of fluorophore-labeled,
soluble molecules and examined their distribution in the draining lymph nodes. Rather than
percolating throughout the draining lymph node, all molecules, including microbial lipopolysac-
charide, were very visible in the subcapsular and medullary sinuses but were largely excluded
from the cortical lymphocyte microenvironments. Exclusion prevailed even during the acute
lymph node enlargement accompanying viral infection. However, low molecular mass (MW)
molecules, including chemokines, did gain entry into the cortex, but in a very defined manner.
Low MW, fluorophore-labeled molecules highlighted the subcapsular sinus, the reticular fibers,
and the abluminal and luminal surfaces of the associated HEVs. These low MW molecules were
in the fibers of the reticular network, a meshwork of collagen fibers ensheathed by fibroblastic
reticular cells that connects the subcapsular sinus floor and the HEVs by intertwining with their
basement membranes. Thus, low MW, lymph-borne molecules, including chemokines, traveled
rapidly from the subcapsular sinus to the HEVs using the reticular network as a conduit.
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Introduction
 
Determining how elements of the immune system come
together and interact in lymphoid tissues is important to
understanding the immune response and its dysregulation.
Much progress has been made in ascertaining the cellular
and molecular events of lymphocyte homing and recircula-
tion, and APC–lymphocyte interactions. However, al-
though the anatomy of the lymphoid tissues in which these
processes occur is well documented, the roles lymphoid
structures play in the orchestration of immune responses
remain to be fully understood.
 
Lymphocytes recirculate through the body via the blood-
stream to lymphoid tissue, such as lymph nodes, where they
search for their respective antigens, then return to the
bloodstream via efferent lymphatics and the thoracic duct
(1). Lymphocytes enter the cortex of the lymph node by
adhering to and migrating across specialized postcapillary
 
venules called high endothelial venules (HEVs),
 
1
 
 found in
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Abbreviations used in this paper:
 
 GAG, glycosaminoglycan; HEL, hen egg
lysozyme; HEV, high endothelial venule; HRP, horseradish peroxidase;
LCA, lens culinaris agglutinin; MIP, macrophage inflammatory protein;
MR, hydrodynamic radius; PSA, pisum sativum agglutinin; RANTES,
regulated upon activation, normal T cell expressed and secreted; SLC,
secondary lymphoid tissue chemoattractant; TEM, transmission electron
microscopy; WGA, wheat germ agglutinin. 
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the T cell–dependent area of the cortex. This process occurs
by an adhesion cascade which includes: (a) rolling of the
lymphocyte on the luminal surface of an HEV, (b) the pres-
ence of a chemokine bound to the endothelial glycocalyx
on the HEV luminal surface triggering the activation of the
integrins on the surface of the lymphocyte, (c) which allow
a firm adherence of the lymphocyte to the endothelium,
and finally, (d) migration of the lymphocyte through the
wall of the HEV into the lymph node parenchyma (2, 3).
Our studies stemmed from a paradox in chemokine dis-
tribution: the presence of macrophage inflammatory pro-
tein (MIP)-1
 
b
 
 on the luminal surface of HEVs in the cor-
tex of a reactive lymph node (4). The presence of a T cell
chemotactic agent on the surface of HEVs is consistent
with a role as an inducer of lymphocyte–endothelial inter-
actions. However, MIP-1
 
b
 
 is not normally expressed by
endothelium (5–7). Interestingly, several studies suggest
that the chemokine need not be synthesized locally in the
lymph node but rather may be lymph borne. The subcuta-
neous injection of the chemokine, secondary lymphoid tis-
sue chemoattractant (SLC), into SLC-deficient mice results
in a detectable accumulation of SLC and adherent lympho-
cytes on the luminal surface of HEVs in the draining lymph
node (8). Increased lymphocyte emigration from HEVs
into the cortex of the draining lymph node occurs within 3
min after a T cell–attracting concentration of IL-8 is in-
jected into the footpad (9). On the other hand, if afferent
lymphatics are ligated, the endothelium of HEVs flattens,
loses expression of L-selectin addressin, and there is a dras-
tic reduction in the number of lymphocytes emigrating
into the lymph node (10–13). Clearly, lymph-borne mate-
rial from draining tissues, which may include chemokines,
not only reaches the HEVs in lymph nodes but may play an
important role in maintenance of high endothelial mor-
phology and lymphocyte migration from HEV into lymph
node cortex.
Previous studies have suggested that afferent lymph-
borne material enters the subcapsular sinus and percolates
throughout the lymph node. This would suggest that drain-
ing lymph diffuses through the lymph node parenchyma to
the HEVs. Nordmann (14) suggested that lymph travels
through the lymph node via the subcapsular and medullary
sinuses, but a small portion of lymph crosses into the corti-
cal parenchyma where it eventually finds its way into the
medullary sinus. Carbon and iron particles and bacterial
components are present in the sinuses as well as the cortical
parenchyma beneath the subcapsular sinus after intralym-
phatic administration (14–19). However, it should be noted
that other studies demonstrate exclusion of the bulk of car-
bon particles from the parenchyma of the cortex (20–22).
Structural studies of the lymph node sinus walls add addi-
tional evidence for the accessibility of the lymph node cor-
tex by lymph. The wall of the subcapsular sinus that is next
to the parenchyma is composed of a layer of sinus endothe-
lial cells separated from a layer of fibroblastic reticular cells
that face the parenchyma by basement membrane and ex-
tracellular matrix (23). The integrity of the floor of the sub-
capsular sinus is a subject of conflicting reports. Ultrastruc-
 
tural studies demonstrate gaps (0.1–1 
 
m
 
m) or pores in the
floor of the subcapsular sinus by electron microscopy (23–
26). An additional study argues against the evidence of gaps
in the floor of the subcapsular sinus (27). Thus, despite the
putative existence of pores in the floor of the subcapsular si-
nus, there is evidence that penetration of particulate mate-
rial from lymph into lymph node cortex is attenuated.
Movement of lymph-borne, soluble material into the
cortex may be governed by different rules than particulate
material. Two intriguing studies demonstrate that although
lymph-borne, soluble molecules filling the sinuses cross
into the cortex, they do not appear to move freely through
the cortical parenchyma of rat lymph nodes. Rather, they
preferentially associate with the reticular network, as well
as highlighting the HEVs (22, 28). The reticular network is
the infrastructure of the lymph node. It is a meshwork of
collagen fibers that extend from the capsule throughout the
node, suspending blood vessels and sinuses. Interestingly,
the reticular network connects the floor of the subcapsular
sinus to HEVs by interweaving its collagen fibers with the
collagen fibers in both the extracellular matrix of the sinus
endothelium and the basement membranes of the HEVs
(23, 29). These reticular fibers are ensheathed by fibroblas-
tic reticular cells (23, 30), thus creating an extracellular
space that is separate from the space that surrounds the
lymphocytes (23). Not only could the reticular network act
as a conduit for the movement of soluble, lymph-borne
material from the subcapsular sinus to the HEV, but the re-
striction of soluble material to the “conduit” would also
protect the milieu of the lymphocyte microenvironments
(22, 23, 28, 31–34).
Given the importance of biological mediators in regulat-
ing lymphocyte migration and responses, it is essential to
understand the rules of distribution of lymph-borne, solu-
ble molecules, such as chemokines, through the cortex and
to the HEVs. Consequently, we have systematically ana-
lyzed distribution of a diverse group of fluorophore-
labeled, soluble molecules in rat and mouse lymph nodes
following subcutaneous injection. In these studies, fluoro-
phore-labeled molecules, draining into the lymph node
from the afferent lymphatic vessel, filled the subcapsular
and medullary sinuses. The majority of molecules exam-
ined were largely excluded from the cortical parenchyma.
Instead, low molecular mass (MW) molecules, including
chemokines, moved from the subcapsular sinus to the
HEVs via the reticular network. Rather than a generalized
percolation of soluble lymph-borne molecules throughout
the parenchyma of the lymph node, these studies demon-
strated a compartmentalization of soluble materials within
the T cell–dependent areas of lymph nodes.
 
Materials and Methods
 
Soluble Molecules
 
All soluble molecules used in these experiments were diluted
in sterile PBS unless otherwise noted. All subcutaneous injections
were 20 
 
m
 
l per site. 
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Reagents, the concentrations used, and their sources are as fol-
lows: acridine orange, hen egg lysozyme (HEL), LPS-FITC (
 
Esch-
erichia coli
 
, serotype 055:B5), and horseradish peroxidase (HRP;
type VI-A) were from Sigma-Aldrich. HEL-FITC was a gift of
Caetano Reis e Sousa (National Institute of Allergy and Infec-
tious Diseases). Acridine orange, HEL-FITC, LPS-FITC, and
HRP were used at 5, 7.5, 5, and 10 mg/ml, respectively. OVA-
FITC was obtained from Molecular Probes and used at 100 
 
m
 
g/
ml. Lysine-fixable, fluorophore-conjugated dextrans were ob-
tained from Molecular Probes and were injected at 5 mg/ml.
Both Texas red–labeled, lysine-fixable dextrans (3, 10, 70, and
2,000 kD) and fluorescein-labeled, lysine-fixable, anionic dex-
trans (3, 10, 40, 70, 500, and 2,000 kD) were used. Lysine-fixable
dextrans have covalently bound lysine residues, which covalently
bind to the immediately surrounding tissue upon aldehyde fixa-
tion. These modified dextrans were used after preliminary studies
showed that, despite aldehyde fixation, generic fluorophore-
labeled dextrans washed out of tissue sections during slide prepa-
ration for microscopy. Anti–mouse MHC class I–FITC (clone
AF6-88.5; BD PharMingen) and mouse anti–human CD3-FITC
(Becton Dickinson) were injected at 50 and 100 
 
m
 
g/ml, respec-
tively. Cy-Chrome–labeled anti–mouse CD45R/B220 was ap-
plied topically to sections on slides at 0.5 
 
m
 
g/ml. FITC-labeled
lectins (Vector Laboratories) wheat germ agglutinin (WGA), lens
culinaris agglutinin (LCA), or pisum sativum agglutinin (PSA)
were injected at 100 
 
m
 
g/ml and applied topically to sections on
slides at 20 
 
m
 
g/ml. Fluorophore-labeled regulated upon activa-
tion, normal T cell expressed and secreted (RANTES), MIP-1
 
a
 
,
and IL-8 (FITC, Cy5) were prepared as described (35). Ly-
ophilized chemokine (10 
 
m
 
g) was dissolved in sterile water (90 
 
m
 
l),
then diluted with 10 
 
m
 
l of sterile 10
 
3
 
 PBS.
 
Animals, Animal Preparation, and Injection of Soluble Molecules
 
All animals were kept in pathogen-free facilities and treated ac-
cording to National Institutes of Health guidelines
 
.
Dextran and HRP Distribution Studies in Rat Mesenteric Lymph
Nodes. 
 
Sprague Dawley and Wistar rats (250–400 g; Charles
River Laboratories) were anesthetized intramuscularly with so-
dium pentobarbital (25 mg/kg; Abbott Laboratories) and ket-
amine HCl (30 mg/kg; Fort Dodge). A midline abdominal inci-
sion opened the peritoneal cavity. The caecum and a few loops of
 
the ileum were exteriorized onto a lucite stage using sterile appli-
cators and superfused with bicarbonate-buffered saline. The saline
was kept at 37
 
8
 
C and equilibrated with 5% CO
 
2
 
 in N
 
2
 
 to a pH of
7.4. Each Peyer’s patch was injected with 0.01–0.02 ml of HRP-
or fluorophore-labeled dextrans using a 28-gauge needle on a
0.5-ml disposable insulin syringe that has 0.01-ml increments (U-
100; Becton Dickinson). Mesenteric lymph nodes were excised
between 3 and 30 min and immersion fixed. For transmission
electron microscopy (TEM) studies of HRP distribution in lymph
nodes, HRP was directly injected intralymphatically and the me-
senteric lymph nodes of Wistar rats were prepared for electron
microscopy as described by Anderson and Anderson (22).
 
Dextran, Tracer, Protein, Antibody, and Chemokine Distribution in
Peripheral Lymph Nodes.
 
Normal female C57BL/6 mice (Na-
tional Cancer Institute Animal Production Area) or Sprague
Dawley or Wistar rats were anesthetized intraperitoneally with
sodium pentobarbital (25 mg/kg; Abbott Laboratories) and ket-
amine HCl (30 mg/kg; Fort Dodge). Each footpad and lip was
injected, subcutaneously, with 0.01–0.02 ml of a soluble molecule
solution using the disposable syringes (Becton Dickinson) de-
scribed above. Draining lymph nodes from the anesthetized ani-
mals were harvested between 3 and 10 min or 30 min after injec-
tion. These times were chosen after preliminary studies showed
that the distribution of soluble molecules was complete in lymph
nodes that had been excised and immersion fixed within 2 min of
the injection. For 4-h time points, animals were anesthetized for
injection and then again for harvest. The superficial cervical, bra-
chial, axillary, inguinal, and popliteal lymph nodes were harvested
(a total of 14 lymph nodes per animal). The distribution of each
soluble molecule was examined in the lymph nodes of three or
more mice, each mouse on a different occasion. In a typical ex-
periment, five mice were used where four mice were injected,
each with a different soluble molecule. The lymph nodes from
those four mice were compared with that of the fifth mouse,
which acted as the control. Note that B10.BR mice (The Jackson
Laboratory) were used for the HEL-FITC distribution studies.
 
Dextran Distribution after Lymph Node Enlargement due to 
Vaccinia Viral Infection
 
Vaccinia virus is a member of the poxvirus family that causes a
rapid and dramatic increase in draining lymph node size after in-
Figure 1. A model of move-
ment of lymph-borne, soluble
molecules through the lymph
node; distribution is dependent
on molecular size. Rather than
percolating through the cortical
parenchyma, soluble molecules
of both high and low MW
moved through the lymph node
via the subcapsular and medul-
lary sinuses (note that cortical si-
nuses are not pictured here). (A)
Although high MW molecules
were excluded from lymph node
cortex and moved through the
lymph node only via the sinuses,
rapid movement of low MW
molecules (B) from the subcap-
sular sinus to the HEVs was re-
stricted to the fibers of the retic-
ular network. (C) Comparison of
the distribution in the lymph node of lymph-borne soluble molecules by size. SCS, subcapsular sinus; T, T cell area; B, B cell area, follicle; RF, reticular
fiber; FRC, fibroblastic reticular cell; G, HEV endothelial glycocalyx; M, medulla. 
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fection. Vaccinia virus stocks (WR; 
 
z
 
2 
 
3
 
 10
 
8
 
 PFU/ml) were
sonicated and 
 
z
 
10
 
7 
 
PFU were injected into the rear footpads of
normal female C57BL/6 mice (Taconic Farms) in 50 
 
m
 
l BSS/
BSA. 8 h after injection of virus, at which point no observable in-
flammation at the site of injection had occurred, a combined so-
lution of Texas red–labeled dextran (10 kD) and fluorescein-
labeled dextran (70 kD), 5 mg/ml each, was injected into the rear
footpads of both virus-injected and control mice. 5 min after
dextran injection, the mice were killed by cervical dislocation
and the popliteal lymph nodes were removed and immersion
fixed
 
.
 
Lymph Node Preparation and Sectioning
 
After excision, draining lymph nodes were immediately placed
in freshly made 4% paraformaldehyde/0.1% glutaraldehyde in 10
mM morpholine propane sulfonic acid (MOPS)-buffered Ringer’s
solution (pH 7.4; room temperature for 1–2 h, then 4
 
8
 
C over-
night). Fixed lymph nodes were washed in PBS for 30 min and
blotted. Fixed or fresh lymph nodes were positioned in moulds
filled with OCT (Baxter), then frozen in an isopentane/dry ice
bath. Lymph nodes were sectioned (10 
 
m
 
m) on a Cryostat micro-
tome. The orientation of the nodes in the moulds resulted in sec-
tions in a vertical plane in relation to the hilar blood vessels (36).
This orientation of the nodes created the greatest number of sec-
tions in parallel to the reticular fibers in the lymph node cortex.
Sections on slides were rehydrated in PBS and coverslipped with
Fluormount (Southern Biotechnology Associates, Inc.).
 
Histochemistry and Immunocytochemistry
 
The reticular network in lymph node sections was stained us-
ing the Gomori reticulin stain (37), as detailed by Mallory (38),
and the chemicals were obtained from Sigma-Aldrich.
To determine the relationship of B cells and HEL-FITC in
lymph nodes after subcutaneous injections of HEL-FITC, lymph
node sections were topically stained with anti–mouse CD45RA/
B220–Cy-Chrome. In brief, fixed lymph node sections (10 
 
m
 
m)
were dried on microscope slides for 1 h, then rehydrated and
washed with PBS and PBS/0.1% BSA for 5 min each. The sec-
tions were incubated for 30 min with anti–CD45RA/B220–Cy-
Chrome (1:100) in PBS/0.1% BSA, followed by three washes
with PBS/0.1% BSA then PBS alone, and coverslipped.
To select lectins that label both lymphocytes and reticular net-
work, a panel of lectins was studied on fresh-frozen sections of
mouse lymph node. Sections were rehydrated, lectin applied, in-
cubated for 30 min, washed three times, fixed, and coverslipped.
To examine the location of lymph-borne dextran in relation
to the reticular fibers and fibroblastic reticular cells, fixed sections
of draining lymph nodes, after a subcutaneous injection of Texas
red–labeled dextran (10 kD), were topically labeled with the lec-
tin, WGA-FITC (10 
 
m
 
g/ml). The sections were manipulated as
described above for labeling with CD45RA/B220.
Controls included fresh-frozen or fixed-frozen lymph node
sections as needed.
 
Microscopy and Image Processing
 
Reticulin stains of lymph node sections were examined using a
ZEISS AxioPlan2 microscope, and differential interference con-
trast (DIC) images were obtained with a Spot-2 CCD camera.
Micrographs of the location of HRP/diaminobenzidine reaction
in relation to the reticular fibers were obtained by TEM (AEI 801
electron microscope; Philips). Images of the distribution of fluo-
rophore-labeled molecules in lymph node sections were collected
using the ZEISS 410 confocal laser scanning microscope. These
images are compiled projections of 30–40 optical sections. Three-
dimensional images were compiled and rotated using Imaris soft-
ware.
 
Results
 
In General, Lymph-borne Molecules Do Not Percolate through
Lymph Node Vortex.
 
We have studied the distribution of a
diverse set of fluorophore-labeled molecules in draining
lymph nodes after subcutaneous injections in both rats and
mice. Two distinct patterns of distribution of soluble,
lymph-borne molecules in the lymph nodes were observed
(Fig. 1). All fluorophore-labeled molecules reached the
draining lymph node and could be seen in the subcapsular
and medullary sinuses. The entry of soluble molecules from
the subcapsular sinus into the cortex was dependent on
 
Table I.
 
Summary of Tracer Characteristics and Their Distribution 
in Lymph Node Cortex
 
Soluble molecule MW MR SCS IC Fiber HEV Ref.
 
kD nm
 
Acridine orange 0.302 0.39
 
11
 
66
Dextran 3 kD
–Fluor or –TR 3.0 1.01
 
161 1
 
67
LPS-FITC 3.4–100 1.07–4.29
 
122 2
 
40, 66
RANTES-Cy5 8.657 1.54
 
121 1
 
66, 68
MIP-1
 
a
 
–FITC 8.303 1.57
 
121 1
 
66, 68
IL-8–FITC 8.941 1.59
 
121 1
 
66, 68
HEL 14.3 1.93
 
121 1
 
39
 
a
 
-Lactalbumin
(bovine) 14.5 2.01
 
121 1
 
69
Dextran 10 kD
–Fluor or –TR 10 2.22
 
121 1
 
70
OVA 48 2.73
 
161 1
 
70
HRP 38 3.02
 
161 1
 
71
WGA 43.2 3.04
 
121 6
 
66
PSA 46 3.12
 
121 6
 
66
LCA 50 3.23
 
121 6
 
66
BSA 68 3.6
 
121 1
 
72
Dextran 40 kD
–Fluor or –TR 37–40 4.0–5.0
 
161 1
 
73
LPS-Fluor 3.4–100 1.07–4.29
 
122 2
 
40, 66
IgG 150 5.34
 
122 2
 
74
Dextran 70 kD
–Fluor or –TR 70 5.5
 
122 2
 
75
Dextran 500 kD
–Fluor 500 11.7
 
122 2
 
75
Dextran 2,000 kD
–TR 2,000 16.0
 
122 2
 
75
SCS, subcapsular sinus; IC, intercellular, in the cortical parenchyma;
Fiber, reticular fiber; Fluor, fluorescein; TR, Texas red. All other
molecules labeled with FITC. Ref., reference(s). 
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molecular size. High MW molecules were undetectable
within the cortex (Fig. 1 A). Conversely, low MW mole-
cules highlighted the reticular network and HEVs in the T
cell–dependent areas of the lymph node cortex (Fig. 1 B),
whereas little fluorescence was detectable between lym-
phocytes in the T cell cortex. Fig. 1 C gives an overview of
the effect of molecular size on distribution in the lymph
node, and all molecules studied, with their distributions
listed in order of their molecular size in Table I.
 
High MW Molecules Excluded from the Cortical Parenchyma
of the Lymph Node.
 
Fluorophore-labeled dextrans (3–
2,000 kD) were used as soluble tracers to test the effect of
size on soluble molecule distribution in the lymph node.
The high MW dextrans, 2,000 and 500 kD (16- and 11.7-
nm hydrodynamic radius [MR]; Table I), are similar in size
to colloidal carbon (with molecular diameters reported as
20–70 nm [39], and 35–45 nm [22]). Like carbon, these
dextrans were easily detectable in the subcapsular sinuses
(Fig. 2 A, 500 kD shown) and medullary sinuses (not
shown). This distribution was also typical for 70-kD dex-
tran (5.5-nm MR; Fig. 3, A and B). However, all three of
these differently sized dextrans were undetectable in the
lymph node cortex.
IgG is similar in molecular size to 70-kD dextran (5.34-
vs. 5.5-nm MR, respectively), yet it is globular in shape,
unlike dextran, which has an extended conformation. The
distribution of FITC-labeled mouse IgG was similar to 70-
kD dextran in that it filled the subcapsular and medullary
sinuses with minimal penetration into the cortex (not
shown). To be certain of the distribution of IgG, both
anti–mouse and anti–rat MHC class I antibodies were used
as “cumulative” markers in mice and rats, respectively. Our
intent was that if the anti–MHC class I antibodies gained
access to the cortical parenchyma, they would bind any
class I–bearing cell they came into contact with and there-
fore would be a record of access. The class I antibodies
were easily detected in the subcapsular and medullary si-
nuses. However, in our studies, lymphocytes in the cortical
microenvironments, which express class I molecules on
their surfaces, were unlabeled with antibody, suggesting
that lymph-borne antibody did not have access to the cor-
tex (Fig. 2 B). These observations suggest the existence of a
barrier that can limit percolation of both proteins and
polysaccharides from lymph into the parenchyma of a
draining lymph node.
Since LPS is a microbial product with profound effects
on cellular immune responses, the accessibility of LPS to
cells within the draining lymph node after administration in
the footpad was studied. The monomeric form of LPS is
3.4 kD; therefore, the distribution might be expected to re-
semble that of low MW molecules. In fact, LPS-FITC was
primarily detectable in the subcapsular and medullary si-
nuses, in a staining pattern similar to those observed after
injection of high MW tracers (Fig. 2 C). This may be ac-
counted for, in part, by physiological aggregation of LPS
monomers into micelles with MW 
 
. 
 
100 kD (40). The
exclusion of LPS is efficient but not always absolute. The
image shown was chosen specifically to show a rare area of
intercellular accumulation in the cortex below the subcap-
sular sinus.
 
Low MW Dextrans and Proteins Gained Access to the Cortex
but Primarily Highlighted the Reticular Network and HEVs in
the Interfollicular Regions.
 
In contrast to the limited distri-
bution of high MW molecules, low MW dextrans (3, 10,
and 40 kD) arriving at the lymph node via lymphatics
gained entry into the cortex, but only in a very defined
manner. The dextrans highlighted distinct structures in the
cortex (Fig. 3, A and B) that appeared identical to the retic-
ular network stained by the Gomori silver stain for reticulin
(Fig. 3 C). Note that both Gomori stain and dextrans high-
light fibers that cross the subcapsular sinus, extend beyond
the floor of the subcapsular sinus into the cortex, and con-
nect to the HEVs. In addition, there are fibers that appear
to begin at the floor of the subcapsular sinus and dive into
Figure 2. Exclusion of high MW molecules and LPS from lymph node cortex. Confocal micrographs showing subcapsular sinuses (between arrows)
and underlying cortices of draining mouse lymph nodes after fluorophore-labeled molecules were injected subcutaneously. The lymph nodes were ex-
cised and immersion fixed within 10–12 min after injection. Lymph node sections, 10 mm thick. Bars, 50 mm. (A) Fluorescein-labeled dextran (500 kD,
green) and Texas red–labeled dextran (2,000 kD, red) in a mouse axillary lymph node after footpad and intravenous injections, respectively. (B) Anti–
mouse MHC class I–FITC (150 kD, white) in mouse lymph node. Inset shows control node; note the autofluorescent cells in both control and experi-
mental conditions due to gain used (C). LPS-FITC (white) in mouse lymph node. Control node in inset. 
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the cortex and may also connect to HEVs. Texas red–
labeled dextran (70 kD) was coadministered with the low
MW dextrans and remained in the subcapsular sinus (yel-
low), indicating that 70-kD dextran exceeded a threshold
for penetration into the parenchyma (Fig. 3, A and B).
Subcutaneous injection of FITC-labeled dextran (70 kD)
combined with Texas red–labeled dextrans (3 and 10 kD)
resulted in a similar distribution, suggesting that charge was
not an issue (data not shown). Upon examination at higher
magnification (Fig. 3 D), fluorophore-labeled dextran (10
kD) appeared to trace an intricate woven pattern around
the HEVs and continued between high endothelial cells
and into the lumen itself. It is likely that the dextran is fol-
lowing the reticular fibers, which interweave with the ex-
tracellular matrix between the fibroblastic reticular cells
that enwrap the HEVs and also with the basement mem-
brane of the high endothelium (29, 41).
Fluorophore-labeled, low MW proteins distributed in
the cortex like the low MW dextrans, primarily associated
with the reticular network and HEVs (Table I). Fig. 4, A
and B, show the distribution of the widely used immuno-
gens, HEL and OVA, in mouse lymph node. Interestingly,
unlike 70-kD dextran, 68-kD BSA highlighted fibers and
 
HEVs in the cortex (not shown here [28]). However, de-
spite the similarity in MW, the molecular radius of albumin
is actually much smaller than 70-kD dextran (3.6 vs. 5.5
nm, respectively). Therefore, the barrier to entry into the
lymph node cortex may be defined to a greater extent by
molecular radius than by absolute MW.
 
Lectin Tracer Demonstrates Movement Is from Subcapsular Si-
nus towards HEVs.
 
In these studies, we used fluorophore-
labeled lectins with low MWs (Table I) to clarify two is-
sues. First, the fluorescent signal of lymph-borne, low MW
molecules was strongest in the subcapsular and medullary
sinuses, followed by that in the fibers of the lymph node
cortex. The arrival of the fluorophore by afferent lymphatic
into the subcapsular sinus suggested that the direction of
movement through the reticular network was in the direc-
tion from subcapsular sinus to HEV. However, most tracers
in our hands distributed within the lymph node too rapidly
to record the direction. As the reticular network spans
between the subcapsular sinus and medullary sinus, we
thought it was important to verify the source and direction
of lymph-borne material through the network. Second, a
dim fluorescence between lymphocytes in the cortical pa-
renchyma was often visible, especially just below the floor
Figure 3. Low MW, soluble
molecules enter lymph node
cortex and distribute in a pattern
resembling reticular network.
Distribution of lymph-borne,
fluorophore-labeled dextrans in
draining rat and mouse lymph
nodes is compared with Gomori
silver staining of the reticular
network in a mouse lymph node
(confocal and bright-field micro-
graphs, respectively). After the
subcutaneous injection of dex-
trans, draining lymph nodes
were excised and immersion
fixed within 10–12 min. Lymph
node sections are 10 mm thick.
Subcapsular sinuses (between ar-
rows) and typical HEVs (arrow-
heads) are labeled. (A) Fluores-
cein-labeled dextran (3 kD,
green) and Texas red–labeled
dextran (70 kD, red). (B) Fluo-
rescein-labeled dextran (40 kD,
green) and Texas red–labeled
dextran (70 kD, red). (C) Go-
mori reticulin stain of mouse
lymph node. (D) Higher magni-
fication of HEVs in rat lymph
node after subcutaneous injec-
tion of Texas red–labeled dex-
tran (10 kD, white). Note the
dextran in lumen (arrow). Bars,
(A–C) 50 mm; (D) 25 mm. 
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of the subcapsular sinus. To determine the extent of soluble
molecule penetration into the lymphocyte environment,
we wanted markers that would bind to the cells and be re-
tained rather than be dependent on fixation of the markers
in place. Lectins that bound both lymphocytes and the re-
ticular network upon topical application on fresh-frozen
lymph node sections included WGA, LCA, and PSA-FITC
(Fig. 5 A). Therefore, these three lectins were studied as
Figure 4. Typical protein immunogens have restricted distribution in cortices of draining lymph nodes after subcutaneous injection. Confocal micro-
graphs of lymph node sections (10 mm) show FITC-labeled protein in subcapsular sinus (between arrows), highlighting reticular network and HEVs (ar-
rowheads). Bars, 50 mm. (A) OVA-FITC (white) in the draining axillary lymph node. Lymph node was excised and fixed 15 min after injection of OVA
into the mouse footpad. (B) HEL-FITC (green) in draining mouse lymph node. Lymph node was excised and fixed 5 min after injection of HEL into the
footpad. Lymph node section was labeled topically with Cy-Chrome–labeled anti–mouse CD45R/B220 antibody to visualize B cells (red).
Figure 5. Lymph-borne molecules travel unidirectionally from the subcapsular sinus (arrows) through the reticular network toward HEVs (small arrow-
heads) in the lymph node cortex and are excluded from the lymphocyte microenvironments. Lymph node sections, 10 mm. Bars, 50 mm. (A) Lympho-
cytes, reticular fibers, and HEVs are visible in this confocal micrograph of a fresh-frozen section of mouse lymph node, topically labeled with FITC-labeled
lectin, PSA (PSA-FITC). (B) Lymph-borne PSA-FITC highlights the subcapsular (arrows) and medullary (large arrowheads) sinuses and an incomplete re-
ticular network starting at the subcapsular sinus. Small arrowheads point to three HEVs that are also highlighted by the lymph-borne PSA-FITC: two
HEVs cut in cross-section (small arrowheads, middle right) and a single HEV with two branches, cut longitudinally (three small arrowheads, top left). Note
the absence of labeled lymphocytes in the cortex. This draining lymph node was excised and fixed 30 min after injection of PSA-FITC into the footpad. 
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lymph tracers like the other molecules studied thus far.
When administered via footpad, the distribution pattern of
the lectins was distinctive and informative. Again, like the
other low MW tracers, the fluorescence signal of FITC-
labeled lectin was in the subcapsular and medullary sinuses
as well as in fibers descending from the subcapsular sinus
(PSA-FITC; Fig. 5 B). Intercellular fluorescence in the
cortex was very low in intensity and only visible just below
the subcapsular sinus for a distance of two to three cell di-
ameters. There appeared to be no difference between the
lymph nodes taken at 5 and 30 min after the subcutaneous
injection in intensity or distance of penetration of the inter-
cellular fluorescence. This confirmed that access of lymph-
borne material to the lymphocytes of the cortical paren-
chyma was restricted.
FITC-labeled lectins filled both the subcapsular and
medullary sinuses as well as highlighted fibers and HEVs
near the floor of the subcapsular sinus. However, unlike
other tracers, the fibers and HEVs in the deeper cortex
were devoid of FITC-labeled lectin, regardless of whether
the draining lymph nodes were removed 3 or 30 min after
subcutaneous injections. Such partial penetration of the
lectins implies a unidirectional movement of tracers within
the reticular network from the subcapsular sinus to the
HEVs.
 
Tracers Found within Reticular Fibers.
 
To determine the
relationship between tracer molecules and reticular fibers,
lymph node sections were examined by confocal micros-
copy and TEM (Fig. 6, A–D). Fig. 6 A shows the distribu-
tion of 10-kD dextran (Texas red labeled) in a rat lymph
node. Four large fibers (red) descend perpendicularly into
the parenchyma from the floor of the subcapsular sinus
(Fig. 6 A, top). These fibers intersect with a capillary that
parallels the floor of the subcapsular sinus, showing inti-
mate connectivity with the vascular system. In addition, the
 
fibers are outlined by a fine green surface stain, FITC-
labeled WGA, consistent with the expected fibroblastic re-
ticular cell outline. In cross-section, both fibers appear
filled with the Texas red–labeled dextran and are bounded
by WGA, suggesting a reticular cell outline (Fig. 6 B). In
Fig. 6 C, a fiber bounded by fibroblastic reticular cells
courses diagonally across the image between two lympho-
cytes in a rat lymph node. Comparison of the electron den-
sity of the fiber to a fiber in a control lymph node from the
same experiment demonstrates the abundance of HRP in
the fiber after intralymphatic injection (Fig. 6, C and D).
These studies indicate that lymph-borne material traffics
through the reticular fibers.
 
Particulate Accumulation of High MW Tracer in Cortex after,
Not during, the Initial Bolus of Soluble Tracer in Subcapsular
Sinus.
 
As shown previously, high MW dextran (green) ad-
ministered subcutaneously arrived rapidly (
 
,
 
5 min) in the
subcapsular and medullary sinuses and was not detectable in
cortex (Fig. 7 A). To determine if the distribution changed,
we extended our time sequence to 30 min and 4 h. At 30
min, the signal for dextran was noticeably lower in subcap-
sular sinus (compared with 5 min) but still high in medulla
with no apparent signal in cortex (Fig. 7 B), consistent with
transit of the majority of dextran through lymph node as a
short-term bolus. At 4 h, the dextran (green) could be seen
in both the subcapsular sinus and cortex but with altered
characteristics (Fig. 7 D). There were high intensity partic-
ulate accumulations of dextran in both the subcapsular si-
nus and cortex, consistent with intracellular accumulation
in phagocytic cells (e.g., dendritic cells and macrophages).
For the 4-h time point, a low MW dextran (10 kD, Texas
red, red) was injected subcutaneously, 10 min before
lymph node removal for both contrast and frame of refer-
ence, as it has been shown to highlight the subcapsular and
medullary sinuses and the reticular network (Fig. 7 D, red).
Figure 6. Lymph-borne, low
MW molecules are in reticular
fibers in the draining lymph
nodes. (A) Confocal microscopy
image of a draining rat mesen-
teric lymph node after the injec-
tion of Texas red–labeled dex-
tran (10 kD, red) into the
associated Peyer’s patch. Reticu-
lar fibers (red) descend vertically
from the dextran-filled subcapsu-
lar sinus (arrows). Topical appli-
cation of the lymph node section
with WGA-FITC (green) high-
lights cells associated with reticu-
lar network. A capillary inter-
twined by the reticular network
runs horizontally across the im-
age (arrowheads). Bar, 18 mm.
(B) Optical cross-section of two
reticular fibers at the white line
in A. Note the Texas red–dex-
tran encircled by WGA-FITC.
Bar, 4 mm. (C and D) TEMs of
reticular fibers ensheathed by fibroblastic reticular cells (arrowheads) in rat mesenteric lymph nodes. L, the nuclei of cortical lymphocytes. In C, the retic-
ular fiber is filled with lymph-borne HRP; D is from the control of the same experiment. 
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Note that the particulate 4-h accumulated tracer in cortex
(green) does not overlap with the 10-min accumulated
tracer highlighting the reticular network (red). However,
in medulla, the signals for both dextrans overlap (Fig. 7 D,
yellow). Thus, medullary accumulation is consistent with
acute uptake from the early bolus of soluble material,
whereas cortical uptake is not. Instead, the lag between the
original bolus (0 h) and cortical accumulation (4 h) suggests
cortical accumulation is from another source, perhaps cel-
lular uptake in tissue.
Rapid Enlargement of Lymph Node due to Viral Infection Had
No Effect on Dextran Distribution. The distribution of dex-
trans and proteins in the lymph node indicated a functional
barrier limiting entry of soluble molecules into the paren-
chyma. However, the lymph node is a dynamic lymphoid
compartment, affected dramatically by inflammatory stim-
uli. To test whether inflammatory stimuli, such as those
generated during infection, affected transport of lymph-
borne solutes, we tested whether the barrier remained in-
tact during a vaccinia virus infection. Vaccinia virus is a
poxvirus known to induce both a large inflammatory re-
sponse and a dramatic increase in the number of lympho-
cytes in the lymph node. The weights of lymph nodes, 8 h
after injection of modified virus, increased by 41% over
that of similar controls (1.2 6 0.1, n 5 3, and 1.7 6 0.2,
n 5 5; mean 6 SD), demonstrating a marked increase in
size of the node. Yet distribution of dextrans was the same in
lymph nodes from control animals (Fig. 8 A) and those in-
fected with vaccinia virus (Fig. 8 B). Fluorescein-labeled
dextran (70 kD) highlighted the sinuses but was excluded
from the parenchyma, whereas Texas red–labeled dextran
(10 kD) selectively decorated fibers and HEVs in draining
lymph nodes. Therefore, the pattern of tracer distribution
did not change, despite dramatic changes in lymph node
size and cellularity during early viral infection.
Lymph-borne Chemokines Gained Access to HEVs via Retic-
ular Network Conduits. After we had established the distri-
bution of low MW molecules, e.g., dextran (10 kD), lactal-
bumin, and HEL, we could finally confront the enigma that
prompted the initiation of these studies: the unexpected lo-
calization of chemokines (8–10 kD) on the luminal surface
of the HEVs. Therefore, we studied the distribution of flu-
orophore-labeled chemokines following footpad injection.
MIP-1a, IL-8, and RANTES (FITC and Cy5) each dis-
tributed in a similar pattern to the other low MW mole-
cules. Fig. 9 illustrates results for MIP-1a–FITC, which
was representative of the three chemokines. Fluorophore-
labeled chemokine was visible in the subcapsular, cortical,
and medullary sinuses. In the T cell–dependent areas, fluo-
rophore-labeled chemokine was visible in the reticular net-
work and around HEVs with little detectable chemokine
intercellularly between lymphocytes. Thus, chemokines in-
jected subcutaneously moved rapidly to the HEVs of the
draining lymph node via the reticular network.
Figure 7. Particulate accumu-
lation of high MW tracer in cor-
tex after, not during, the initial
bolus of soluble tracer in subcap-
sular sinus. (A) High MW dex-
tran only in subcapsular sinus
(arrows) at 5 min after subcuta-
neous injection. (B) At 30 min,
lower intensity signal of high
MW dextran in subcapsular sinus
(arrows) but high persistent sig-
nal in medulla (on right). (C)
Control lymph node. (D) Mon-
tage of adjacent areas of popliteal
lymph node. Focal accumulation
of high MW dextran (2,000 kD,
fluorescein labeled, green) at 4 h
within parenchyma contrasts
with reticular-type distribution
of low MW dextran (10 kD,
Texas red, red) at 10 min (sub-
capsular sinus, arrows; HEV, ar-
rowheads). However, despite
different times of administra-
tion, both tracers coaccumu-
lated in a cellular-type distribu-
tion within a medullary sinus.
Bars, 50 mm.1434 Barriers and Conduits in Lymph Nodes
Discussion
These studies have two distinct functional implications
regarding the access and delivery of lymph-borne soluble
molecules to the cortex of a draining lymph node. First,
penetration of lymph-borne, soluble molecules into the
cortical parenchyma, an area where T cell–APC interac-
tions occur, is restricted. Second, low MW, lymph-borne,
soluble molecules move rapidly through the lymph node
cortex to the HEVs via a remarkable anatomic network,
thus assuring access of chemokines and other soluble medi-
ators to the HEVs.
It is generally accepted that lymph flows into the subcap-
sular sinus of the draining lymph node, through to the
medullary sinus, and exits the lymph node at the hilum as
efferent lymph. In addition, some studies suggest that a
portion of lymph leaves the subcapsular sinus and perco-
lates through the lymph node cortex (14, 16). Percolation
is conceptually appealing, as it would assure access of solu-
ble factors to lymphocytes and APCs, as well as stromal and
other immune cells in the cortex, and therefore directly
contribute to the immune response. The possibility of per-
colation is further supported by studies of the subcapsular
sinus floor using electron microscopy. The physical struc-
ture across which soluble molecules would have to move is
composed of extracellular matrix sandwiched between si-
nus endothelium on the floor of the sinus and fibroblastic
reticular cells facing the cortex (23, 24). Some, but not
other electron microscopic studies indicate pores or gaps in
one or the other cell layers of the floor of the subcapsular
sinus (23, 24, 26, 27, 42). Anatomic evidence notwith-
standing, our functional data strongly indicated that there
was a functional barrier that restricted “percolation” of sol-
uble, lymph-borne molecules into the cortex.
The efficiency of the barrier depended on the size of the
lymph-borne molecules. High MW tracers appeared to be
virtually excluded (Fig. 2); as high MW tracer was abun-
dant in subcapsular sinus but absent in adjacent cortex, this
Figure 8. Despite acute changes in lymph node system during viral in-
fection, patterns of distribution of lymph-borne, soluble molecules are
preserved. Montages of confocal images of lymph node sections (10 mm)
from control (A) and virally infected (B) draining mouse popliteal lymph
nodes are presented here. Mouse popliteal lymph nodes were excised and
immersion fixed 5 min after footpads were injected with fixable, fluoro-
phore-labeled dextrans (10-kD dextran–Texas red [red], and 70-kD dex-
tran–fluorescein [green]). Bar, 160 mm. (A) Control lymph node. (B) Vi-
rally infected lymph node, 8 h after footpad injection with modified
vaccinia virus. Note that both low and high MW fluorophore-labeled
dextrans filled the subcapsular (arrows) and medullary sinuses (arrow-
heads), whereas the lower MW dextran (red) highlights the reticular net-
work and associated HEVs in the cortex of each lymph node.
Figure 9. Lymph-borne chemokines travel to HEVs via reticular network “conduits.” Confocal images shown of lymph-borne MIP-1a–FITC in sub-
capsular sinus (arrows), cortical/medullary sinuses (large arrowheads), and reticular fibers descending from the subcapsular sinus floor to several HEVs
(small arrowheads) in a draining mouse axillary lymph node. The lymph node was excised and immersion fixed 15 min after subcutaneous injection of
the chemokine into the footpad. (A) Cortex. (B) Cortical/medullary sinuses (large arrowheads). (C) Control showing autofluorescent cells due to gain
used. Bars, 50 mm.1435 Gretz et al.
demonstrated that the floor of the subcapsular sinus that
separates subcapsular sinus from cortex was an efficient
functional barrier for high MW material. In contrast, for
low MW tracers the exclusion was partial, not absolute.
Specifically, there was detectable tracer in the cortex, on
occasion, seen as faint outlining of lymphocytes within the
parenchyma (e.g., Figs. 3 and 4). That signal, when ob-
served, was at a level several-fold weaker than adjacent sub-
capsular sinus or reticular network; any detectable cortical
signal was generally evident subjacent to the subcapsular si-
nus with less or no signal in the deep cortex. A limit to the
protection of the cortical parenchyma by this functional
barrier is demonstrated by the free movement of very small
molecules such as tritiated uridine (z350 daltons; reference
43) and acridine orange (302 daltons; our data not shown)
throughout the cortex.
Restricted access of lymph-borne material to cortical pa-
renchyma would not only preserve the milieu of lympho-
cyte microenvironments, but also protect the lymphocytes
from a potentially varied collection of lymph-borne sub-
stances. This would be especially advantageous with those
substances that would adversely influence an immune re-
sponse occurring within the cortex. For example, during
microbial infections, this barrier may be important for ex-
clusion not only of the microbes themselves, but also of
their soluble products, which can perturb immune re-
sponses. Our findings of microbial LPS in the subcapsular
and medullary sinuses, rather than in the cortex, illustrated
such exclusion. The adaptability of the lymph node and
this functional barrier became evident during an induced
viral infection with vaccinia virus. The increase in lymph
node weights 8 h after injection of vaccinia virus, com-
pared with similar controls, suggested that the surface area
of the floor of the subcapsular sinus had increased by
z30%. However, the distribution of fluorophore-labeled
dextrans did not change, demonstrating that this functional
boundary remained intact even in the event of acute en-
largement of the lymph node during viral infection. Thus,
this functional barrier may isolate the cortex from a poten-
tially varied collection of substances, which would impair
the immunological response. On the other hand, this func-
tional barrier will limit the ability of APCs already in the
cortex to acquire lymph-borne antigen. The timing and
pattern of accumulation of high MW tracer within cortex
(Fig. 7) fits the interpretation that delayed (4 h) appearance
of tracer in cortex may be due to cellular uptake in the pe-
riphery rather than cellular uptake in the draining lymph
node. The attenuation of uptake of low MW molecules by
cortical-resident APCs will be quantitative not qualitative,
as the restriction of tracer entry is relative and not absolute;
consequently, its relevance would be greatest for immune
challenges in which antigen concentration is limited.
Existence of the barrier discussed above poses a problem,
as it would restrict access of lymph-borne material to
HEVs, which are all located exclusively within the cortex.
Nevertheless, even with this barrier in place, soluble tracers
find their way to the HEVs. Previous studies show that
rather than the diffuse distribution of soluble molecules as
expected for percolation through the cortex, the proteins
BSA-FITC, HRP, and Ig-FITC highlight the reticular
network and HEVs in the cortex (22, 28). In our studies,
we found that in addition to HRP and BSA-FITC, several
other molecules comparable in size distributed in a similar
fashion (Table I). However, in our results, IgG-FITC re-
mained in the sinuses in both rats and mice, much like dex-
tran (70 kD), suggesting that molecules above a certain
threshold in size are excluded from not only the lympho-
cyte environment but also the reticular network. The cut-
off for access to the reticular network was a molecular di-
ameter between 7.2 and 10.7 nm, as demonstrated by the
respective distributions of BSA and IgG. Preferential access
to the reticular network relative to the lymphocyte envi-
ronment continued to be demonstrated with smaller mole-
cules, such as a-lactalbumin, 3-kD dextran (4- and z2-nm
molecular diameter, respectively), and chemokines.
The direction of flow of lymph through the lymph
nodes of rats and mice is from the afferent lymphatics into
the lymph node subcapsular sinus, and from there through
the medullary sinus and out through the efferent lymphatic
vessel. Therefore, it was logical that the direction of move-
ment of lymph-borne material through the reticular net-
work would be from subcapsular sinus to HEVs (28).
However, the reticular fibers often extend from there to
the medullary sinus; therefore the medullary sinus could, in
theory, be a source of lymph for passage through the retic-
ular network. Sainte-Marie and Peng (28) show a gradient
of BSA from subcapsular sinus to HEVs. We confirmed
that the direction of movement of lymph-borne material
was from subcapsular sinus towards HEVs through the re-
ticular network by using FITC-labeled lectins as lymph-
borne tracers. The penetration of the lectins through the
network was never as complete as other proteins, regardless
of whether the draining lymph node was removed 3 or 30
min after subcutaneous injection. Nonetheless, the pene-
tration through the reticular network always started at the
subcapsular sinus despite the presence of lectin in the med-
ullary sinus. The limited movement of the lectins through
the reticular network may be due to interactions with pro-
teoglycans and glycosaminoglycans (GAGs) associated with
the collagens of the reticular network (44).
The movement of tracer molecules through the conduits
is most consistent with bulk flow of water and tracers via
the conduits. It is remarkable that bulk flow occurs along
conduits, given that the hydrostatic pressure is low in affer-
ent lymph, and that there is little resistance to its outflow
via sinuses to the efferent lymphatics. These considerations
argue that there must be special mechanisms which give
rise to the transport observed. Three kinds of special mech-
anisms may be involved. (a) Active transport at the floor of
the subcapsular sinus. Compton and Raviola (45) noted
that there is an extraordinary abundance of vesicles in the
sinus lining cells, so much so that a role in transport was
considered but discounted because no transport across this
barrier was expected. (b) Pressure source from fenestrated
capillaries. Fenestrated capillaries intersect with reticular fi-
bers just below the floor of the subcapsular sinus. Intravas-1436 Barriers and Conduits in Lymph Nodes
cular injections of HRP have been shown to enter the re-
ticular network with a decreasing gradient extending from
these sites (22). Thus, fenestrations could allow fluid move-
ment from the capillary into the conduit, providing addi-
tional hydrostatic pressure to drive flow towards the lower
pressure in the venous system. (c) Active transport at the
site of HEV outflow. Antal Rot and coworkers (46, 47)
have demonstrated vesicular transport of chemokine from
the abluminal to luminal surface of the venular endothe-
lium. A combination of these three mechanisms probably
gives rise to the tracer movement observed. Fluid volume
transported by vesicle traffic would probably be insufficient
to account for the observed rate of flow via the conduits.
However, vesicular transport of tracer, coupled with bulk
flow driven by fenestrated capillaries, might be sufficient.
Fluid movement along collagen fibers occurs in the in-
terstitium of other tissues (48–53). Reticular fibers in the
lymph node are distinctive in that each fiber is ensheathed
by fibroblastic reticular cells (30). Therefore, each fiber is in
an extracellular space distinct from the interstitial space of
the parenchyma and continuous with the fibers in the floor
of the subcapsular sinus and those enwrapping the HEVs
(23, 29). Both Rinehart (54) and Moe (23) hypothesized
that fluid movement might be directed along these fibers.
Anderson and Anderson (22) and Sainte-Marie and Peng
(28) showed preferential localization of several tracers along
reticular fibers in rat lymph nodes between the subcapsular
sinus and the HEVs, which are confirmed here. By extend-
ing the studies into the mouse with a wider range of trac-
ers, we have revealed that molecular size was a factor in the
access of lymph-borne soluble molecules to the reticular
network. Both confocal microscopy and TEM confirmed
that the tracer was localized within the reticular fiber rather
than outside the ensheathing fibroblastic reticular cell.
Thus, fluid movement within the reticular network in
lymph node is a special case of the more general biological
strategy of fluid movement along collagen fibers.
These findings may also have implications for B cell ac-
quisition of antigen in lymph nodes. At the HEVs, low
MW lymph-borne material arriving via the reticular net-
work filled the perivenular channel and interendothelial
spaces, i.e., between the endothelium and the layers of fi-
broblastic reticular cells enwrapping the HEVs and be-
tween the high endothelial cells. Incoming lymphocytes
migrate through these spaces on their way from the HEV
lumen to the cortical parenchyma. At this point, lympho-
cytes are bathed in the low MW lymph-borne molecules
that arrive via the reticular network. This may then be a
site where antigen-specific B cells could capture their solu-
ble antigen and carry it with them into the cortex for pre-
sentation to T cells. In this context, it may be noteworthy
that most “model antigens” like HEL and OVA are small
enough to move through the reticular network to the
HEVs.
Soluble mediators appear to be important for the pheno-
type of HEVs and the migratory events that occur there.
SLC expressed by high endothelium promotes adhesion
and chemotaxis of lymphocytes in lymph nodes (8, 55, 56).
In addition, the specificity of chemokines for leukocyte
subpopulations suggests that chemokines immobilized on
endothelial glycocalyx may be involved in selective recruit-
ment of leukocytes at postcapillary venules in general, and
HEVs in particular (4, 57–59). An additional layer of selec-
tivity and specificity lies with the interaction of chemokines
to GAG subgroups in the endothelial glycocalyx or extra-
cellular matrix (60–63). Therefore, the endothelial expres-
sion of GAGs luminally and abluminally plays an additional
role in leukocyte recruitment. The access for chemokines
draining from insulted tissue to the HEVs via the reticular
network provides a means for additional recruitment. In ad-
dition, onset of such affects would occur rapidly after such
soluble molecules were released from the draining tissue,
but could be sustained as long as such molecules were being
released. Moreover, inflammatory cytokines such as IL-1,
TNF, and IFN-g, which regulate intermediate and long-
term endothelial phenotype (e.g., their expression of intra-
cellular adhesion molecule [ICAM]-1 and vascular cell
adhesion molecule [VCAM]-1 involved in leukocyte re-
cruitment), could also reach the HEVs via this route (64, 65).
Our studies showed that chemokines travel through the
reticular network to HEVs, thus providing an explanation
for chemokine on the luminal surface of an HEV that does
not produce it (4, 8). A diverse group of molecules are
likely to travel to HEVs via this route in vivo, including a
variety of soluble mediators that could be physiologically
important both abluminally and luminally at the HEVs.
Therefore, the reticular network is positioned to play an
important role in the orchestration of lymphocyte recircu-
lation and immune responses by acting as a conduit for the
delivery of small, lymph-borne molecules, including anti-
gens and chemokines, from subcapsular sinus to HEVs.
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